-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Downgrades Avalo Therapeutics to Neutral

Benzinga·10/23/2026 10:30:02
Listen to the news
HC Wainwright & Co. analyst Mitchell S. Kapoor downgrades Avalo Therapeutics (NASDAQ:AVTX) from Buy to Neutral.